A Novel Anti-HER2 Antibody-Drug Conjugate XMT-1522 for HER2-Positive Breast and Gastric Cancers Resistant to Trastuzumab Emtansine

V. Le Joncour, A. Martins, M. Puhka, J. Isola, M. Salmikangas, P. Laakkonen, H. Joensuu, M. Barok

    Research output: Contribution to journalArticleScientificpeer-review

    15 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)1721-1730
    JournalMolecular cancer therapeutics
    Issue number10
    Publication statusPublished - 2019
    Publication typeA1 Journal article-refereed


    • HER2
    • T-DM1
    • XMT-1522
    • antibody-drug conjugate
    • breast cancer
    • gastric cancer

    Publication forum classification

    • Publication forum level 1

    Cite this